Intraperitoneal administration of coumarin causes tissue-selective depletion of cytochromes p450 and cytotoxicity in the olfactory mucosa

Toxicology and Applied Pharmacology

Volumn 146, Issue 1, 1997, Pages 134-143

  Gu, Jun ^a   Walker, Vernon E ^a   Lipinskas, Thomas W ^a   Walker, Dale M ^a   Ding, Xinxin ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN; COUMARIN DERIVATIVE; CYTOCHROME P450; UMBELLIFERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INDUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NOSE MUCOSA; OLFACTORY EPITHELIUM; ORAL DRUG ADMINISTRATION; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030883797     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8238     Document Type: Article

References (48)

1. Belinsky S. A., Walker V. E., Maronpot R. R., Swenberg J. A., Anderson M. W. Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to tobacco-specific nitrosamine 4-(NN. Cancer Res. 47:1987;6058-6065.
2. Béréziat J.-C., Raffalli F., Schmezer P., Frei E., Geneste O., Lang M. A. Cytochrome P450 2A of nasal epithelium: regulation and role in carcinogen metabolism. Mol. Carcinog. 14:1995;130-139.
3. Bogdanffy M. S. Biotransformation enzymes in the rodent nasal mucosa: The value of a histochemical approach. Environ. Health Perspect. 85:1990;177-186.
4. Bonnefoi M., Monticello T. M., Morgan K. T. Toxic and neoplastic responses in the nasal passages: Future research needs. Exp. Lung Res. 17:1991;853-868.
5. Brandt I., Brittebo E. B., Feil V. J., Bakke J. E. Irreversible binding and toxicity of the herbicide dichlobenil (2,6-dichlorobenzonitrile) in the olfactory mucosa of mice. Toxicol. Appl. Pharmacol. 103:1990;491-501.
6. Brittebo E. B. Metabolism of xenobiotics in the nasal olfactory mucosa: Implications for local toxicity. Pharmacol. Toxicol. 72:1993;50-52.
7. Brittebo E. B. Metabolism-dependent toxicity of methimazole in the olfactory mucosa. Pharmacol. Toxicol. 76:1995;76-79.
8. Carlton B. D., Aubrun J.-C., Simon G. S. Effects of coumarin following perinatal and chronic exposure in sprague-Dawley rats and CD-1 mice. Fundam. Appl. Toxicol. 30:1996;145-151.
9. Dahl A. R., Hadley W. M. Nasal cavity enzymes involved in xenobiotic metabolism: Effects on the toxicity of inhalants. CRC Crit. Rev. Toxicol. 21:1991;345-372.
10. Deamer N. J., O'Callaghan J. P., Genter M. B. Olfactory toxicity resulting from dermal application of 2,6-dichlorobenzonitrile (dichlobenil) in the C57B1 mouse. NeuroToxicology. 15:1994;287-294.
11. Ding X., Coon M. J. Purification and characterization of two unique forms of cytochrome P-450 from rabbit nasal microsomes. Biochemistry. 27:1988;8330-8337.
12. Ding X., Coon M. J. Immunochemical characterization of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue-specific expression of P450s NMa and NMb. Mol. Pharmacol. 37:1990;489-496.
13. Ding X., Coon M. J. Olfactory cytochrome P450. Handbook Exp. Pharmacol. 105:1993;351-361.
14. ALC. Mol. Pharmaco. 30:1986;370-378.
15. Ding X., Peng H.-M., Coon M. J. Cytochromes P450 NMa, NMb (2G1), and LM4 (IA2) are differentially expressed during development in rabbit olfactory mucosa and liver. Mol. Pharmacol. 42:1992;1027-1032.
16. Ding X., Spink D. C., Bhama J. K., Sheng J., Vaz A. D. N., Coon M. J. Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450. Mol. Pharmacol. 49:1996;1113-1121.
17. Eriksson C., Brittebo E. B. Metabolic activation of the olfactory toxicant, dichlobenil, in rat olfactory microsomes: Comparative studies with p-nitrophenol. Chem.-Biol. Interact. 94:1995;183-196.
18. Genter M. B., Llorens J., O'Callaghan J. P., Peele D. B., Morgan K. T., Crofton K. M. Olfactory toxicity of β,β′-iminodipropionitrile in the rat. J. Pharmacol. Exp. Ther. 263:1992;1432-1439.
19. Greenlee W. F., Poland A. An improved assay of 7-ethoxycoumarinOp. J. Pharmacol. Exp. Ther. 205:1978;596-605.
20. Guo Z., Smith T. J., Thomas P. E., Yang C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. Arch. Biochem. Biophys. 298:1992;279-286.
21. Hong J.-Y., Ding X., Smith T. J., Coon M. J., Yang C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen by rabbit nasal microsomes and cytochrome P450s NMa and NMb. Carcinogenesis. 13:1992;2141-2144.
22. Hurtt M. E., Thomas D. A., Working P. K., Monticello T. M., Morgan K. T. Degeneration and regeneration of the olfactory epithelium following inhalation exposure to methyl bromide: Pathology, cell kinetics, and olfactory function. Toxicol. Appl. Pharmacol. 94:1988;311-328.
23. Jeffery E. H., Haschek W. M. Protection by dimethyl sulfoxide against acetaminophen-induced hepatic, but not respiratory toxicity in the mouse. Toxicol. Appl. Pharmacol. 93:1988;452-461.
24. Kimura S., Kozak C. A., Gonzalez F. J. Identification of a novel P450 expressed in rat lung: cDNA cloning and sequence, chromosome mapping, and induction by 3-methylcholanthrene. Biochemistry. 28:1989;3798-3803.
25. Koop D. R., Nordblom G. D., Coon M. J. Immunochemical evidence for a role of cytochrome P-450 in liver microsomal ethanol oxidation. Arch. Biochem. Biophys. 235:1984;228-238.
26. Lake B. G. Investigations into the mechanism of coumarin-induced hepatotoxicity in the rat. Arch. Toxicol. 7:1984;16-29.
27. Lake B. G., Gray T. J. B., Evans J. G., Lewis D. F. V., Beamand J. A., Hue K. L. Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: comparison with dihydrocoumarin and other coumarin metabolites. Toxicol. Appl. Pharmacol. 97:1989;311-323.
28. Larsson P., Pettersson H., Tjalve H. Metabolism of AFBI in the bovine olfactory mucosa. Carcinogenesis. 10:1989;1113-1118.
29. Lewis J. L., Hahn F. F., Dahl A. R. Transport of inhaled toxicants to the central nervous system: characteristics of a Nose-brain barrier. The Vulnerable Brain and Environmental Risks. Toxins in Air and Water. 3:1994;Plenum, New York. p. 77-103.
30. Liu C., Zhuo X., Gonzalez F. J., Ding X. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2A6: role in metabolic activation of nasal toxicants. Mol. Pharmacol. 50:1996;781-788.
31. Marshall M. E., Mohler J. L., Edmond K., Williams B., Butler K., Ryles M., Weiss L., Urban D., Bueschen A., Markiewicz M., Cloud G. An update review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin. J. Cancer Res. Clin. Oncol. 120:1994;S39-S42.
32. National Toxicology Program, 1993, Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies), U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
33. Nef P., Heldman J., Lazard D., Margalit T., Jaye M., Hanukoglu I., Lancet D. Olfactory-specific cytochrome P-450: cDNA cloning of a novel neuroepithelial enzyme possibly involved in chemoreception. J. Biol. Chem. 264:1989;6780-6785.
34. Negishi M., Lindberg R., Burkhart B., Ichikawa T., Honkakoski P., Lang M. Mouse steroid 15α-hydroxylase gene family: Identification of type II P-45015α as coumarin 7-hydroxylase. Biochemistry. 28:1989;4169-4172.
35. Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1-42.
36. Omura T., Sato R. The carbon monoxide-binding protein of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239:1964;2370-2378.
37. Opdyke D. L. J. Monographs on fragrance raw materials; coumarin. Food Chem. Toxicol. 12:1974;385-388.
38. Peele D. B., Allison S., Bolon B., Prah J. D., Jensen K. F., Morgan K. T. Functional deficits produced by 3-methylindole-induced olfactory mucosal damage revealed by a simple olfactory learning task. Toxicol. Appl. Pharmacol. 107:1991;191-202.
39. Peng H.-M., Ding X., Coon M. J. Isolation and heterologous expression of cloned cDNAs for two rabbit nasal microsomal proteins, CYP2A10 and CYP2A11, that are related to nasal microsomal cytochrome P450 form a. J. Biol. Chem. 268:1993;17253-17260.
40. 14. Xenobiotica. 21:1991;499-514.
41. Putt D., Ding X., Coon M. J., Hollenberg P. F. Metabolism of aflatoxin B1 by rabbit and rat nasal mucosa microsomes and purified cytochrome P450, including isoforms 2A10 and 2A11. Carcinogenesis. 16:1995;1411-1417.
42. Reed C. J., Lock E. A., De Matteis F. NADPH: Cytochrome P-450 reductase in olfactory epithelium - Relevance to cytochrome P-450-dependent reactions. Biochem. J. 240:1986;585-592.
43. Reed C. J. Drug metabolism in the nasal cavity: Relevance to toxicology. Drug Metab. Rev. 25:1993;173-205.
44. Shilling W. H., Crampton R. F., Longland R. C. Metabolism of coumarin in man. Nature (London). 221:1969;664-665.
45. Su T., Sheng J. J., Thomas L. W., Ding X. Expression of CYP2A genes in rodent and human nasal mucosa. Drug Metab. Dispos. 24:1996;884-890.
46. Thornton-Manning J. R., Nikula K. J., Hotchkiss J. A., Avila K. J., Rohrbacher K. D., Ding X., Dahl A. R. Nasal cytochrome P450 2A: Identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen. Toxicol. Appl. Pharmacol. 142:1996;22-30.
47. Uraih L. C., Maronpot R. R. Normal histology of the nasal cavity and application of special techniques. Environ. Health Perspect. 85:1990;187-208.
48. Young J. T. Histopathologic examination of the rat nasal cavity. Fundam. Appl. Toxicol. 1:1981;309-312.